Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial.
Merrill JT, Tanaka Y, D'Cruz D, Vila-Rivera K, Siri D, Zeng X, Saxena A, Aringer M, D'Silva KM, Cheng L, Mohamed MF, Siovitz L, Bhatnagar S, Gaudreau MC, Doan TT, Friedman A.
Merrill JT, et al. Among authors: d silva km.
Arthritis Rheumatol. 2024 Jun 24. doi: 10.1002/art.42926. Online ahead of print.
Arthritis Rheumatol. 2024.
PMID: 38923871